Contemporary view of the clinical relevance of magnesium homeostasis

被引:81
作者
Ayuk, John [1 ]
Gittoes, Neil J. L. [1 ]
机构
[1] Queen Elizabeth Hosp, Dept Endocrinol, Birmingham B15 2TH, W Midlands, England
关键词
Magnesium; hypomagnesaemia; hypermagnesaemia; electrolyte metabolism; proton-pump inhibitor; PROTON-PUMP INHIBITORS; MG2+ CHANNEL TRPM6; INTESTINAL-ABSORPTION; HYPOMAGNESEMIA; HYPERMAGNESEMIA; CALCIUM; FOOD; METABOLISM; DISORDERS; THERAPY;
D O I
10.1177/0004563213517628
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Magnesium is one of the most abundant cations in the body and is essential for a wide variety of metabolically important reactions. Serum magnesium concentration is regulated by the balance between intestinal absorption and renal excretion. Hypomagnesaemia is relatively common, with an estimated prevalence in the general population ranging from 2.5 to 15%. It may result from inadequate magnesium intake, increased gastrointestinal or renal loss or redistribution from extracellular to intracellular space. Drug-induced hypomagnesaemia, particularly related to proton-pump inhibitor (PPI) therapy, is being increasingly recognized. Although most patients with hypomagnesaemia are asymptomatic, manifestations may include neuromuscular, cardiovascular and metabolic features. Due to the kidney's ability to increase fractional excretion to nearly 100% when the renal magnesium threshold is exceeded, clinically significant hypermagnesaemia is uncommon, generally occurring only in the setting of renal insufficiency and excessive magnesium intake. Symptoms include hypotension, nausea, facial flushing, ileus and flaccid muscle paralysis. In most cases, simply withdrawing exogenous magnesium is sufficient to restore normal magnesium concentrations, although occasionally administration of intravenous calcium or even dialysis may be required.
引用
收藏
页码:179 / 188
页数:10
相关论文
共 53 条
  • [1] Agus ZS, 1999, J AM SOC NEPHROL, V10, P1616
  • [2] Claudins of intestine and nephron - a correlation of molecular tight junction structure and barrier function
    Amasheh, S.
    Fromm, M.
    Guenzel, D.
    [J]. ACTA PHYSIOLOGICA, 2011, 201 (01) : 133 - 140
  • [3] Assadi F, 2010, IRAN J KIDNEY DIS, V4, P13
  • [4] Drug-induced hypomagnesaemia - Scope and management
    Atsmon, J
    Dolev, E
    [J]. DRUG SAFETY, 2005, 28 (09) : 763 - 788
  • [5] How should hypomagnesaemia be investigated and treated?
    Ayuk, John
    Gittoes, Neil J. L.
    [J]. CLINICAL ENDOCRINOLOGY, 2011, 75 (06) : 743 - 746
  • [6] BOHMAN VR, 1990, OBSTET GYNECOL, V76, P984
  • [7] HUNGRY BONE SYNDROME - CLINICAL AND BIOCHEMICAL PREDICTORS OF ITS OCCURRENCE AFTER PARATHYROID SURGERY
    BRASIER, AR
    NUSSBAUM, SR
    [J]. AMERICAN JOURNAL OF MEDICINE, 1988, 84 (04) : 654 - 660
  • [8] Regulation of the Epithelial Mg2+ Channel TRPM6 by Estrogen and the Associated Repressor Protein of Estrogen Receptor Activity (REA)
    Cao, Gang
    van der Wijst, Jenny
    van der Kemp, AnneMiete
    van Zeeland, Femke
    Bindels, Rene J.
    Hoenderop, Joost G.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (22) : 14788 - 14795
  • [9] HYPOMAGNESEMIA IN PATIENTS IN POSTOPERATIVE INTENSIVE-CARE
    CHERNOW, B
    BAMBERGER, S
    STOIKO, M
    VADNAIS, M
    MILLS, S
    HOELLERICH, V
    WARSHAW, AL
    [J]. CHEST, 1989, 95 (02) : 391 - 397
  • [10] THE INFLUENCE OF HYPERMAGNESEMIA ON SERUM-CALCIUM AND PARATHYROID-HORMONE LEVELS IN HUMAN-SUBJECTS
    CHOLST, IN
    STEINBERG, SF
    TROPPER, PJ
    FOX, HE
    SEGRE, GV
    BILEZIKIAN, JP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (19) : 1221 - 1225